Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
Hybrid macrophage-mitochondria extracellular vesicles for mitochondrial ROS regulation in diabetic wounds
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 28 February 2026

Hybrid macrophage-mitochondria extracellular vesicles for mitochondrial ROS regulation in diabetic wounds

  • Li Fan1 na1,
  • Changhe Zhang2 na1,
  • Zhigang Xu1,
  • Zhelong Li3,
  • Bin Zhang3,
  • Heng Li1,
  • Jingxiang Wang1,
  • Zhao Wei4,
  • Juntao Han1,
  • Hao Guan  ORCID: orcid.org/0000-0002-5132-40781,
  • Bo Peng  ORCID: orcid.org/0000-0002-7626-84555,
  • Nicolas H. Voelcker  ORCID: orcid.org/0000-0002-1536-78042,6,7 &
  • …
  • Xuekang Yang  ORCID: orcid.org/0000-0002-7318-89271 

Nature Communications , Article number:  (2026) Cite this article

  • 6134 Accesses

  • 1 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cell delivery
  • Mitochondria
  • Nanobiotechnology

Abstract

Precise regulation of mitochondrial reactive oxygen species (mtROS) in macrophages is essential for reducing inflammation and promoting diabetic wound healing. However, achieving targeted and responsive mtROS modulation in specific cell remains challenging. Herein, we report a macrophage-mitochondria hybrid membrane derived artificial extracellular vesicle platform (C@AH-EV). C@AH-EV integrates biomimetic dual-targeting membranes with an mtROS activatable prodrug. It leverages membrane protein-mediated targeting of macrophage mitochondria to offer highly selective intracellular delivery. The payload is a ROS sensitive antioxidant prodrug, which incorporates lipid tails that enhance its drug loading efficiency in vesicles. Upon mtROS-triggered cleavage of the boronate ester bond, potent antioxidants were locally released within the mitochondria to restore redox balance. In vitro and in vivo studies demonstrate that C@AH-EVs effectively reprogram macrophages from an inflammatory toward an anti-inflammatory phenotype, thereby attenuating inflammation and accelerating diabetic wound repair. This work offers a promising direction for treating chronic inflammatory conditions.

Similar content being viewed by others

Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects

Article Open access 16 March 2022

Reprogramming mitochondrial metabolism and epigenetics of macrophages via miR-10a liposomes for atherosclerosis therapy

Article Open access 14 October 2025

Engineering biomaterials to tailor the microenvironment for macrophage–endothelium interactions

Article 04 September 2023

Data availability

The data that support the findings of this study are available within the article and its Supplementary Information files. Source data are available for Figs. 2d–g, i, 3e, g–i, 5b, h, k, 6b, c, g, h, 7b, c, e, f, 8a–f and 9d, Supplementary Figs. 16, 19, 21, 22, 26–30 and 34–43. Source data are provided with this paper.

References

  1. Zhang, Y. et al. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 43, 964–974 (2020).

    Google Scholar 

  2. Powers, J. G., Higham, C., Broussard, K. & Phillips, T. J. Wound healing and treating wounds: chronic wound care and management. J. Am. Acad. Dermatol. 74, 607–625 (2016).

    Google Scholar 

  3. Lipsky, B. A. A current approach to diabetic foot infections. Curr. Infect. Dis. Rep. 1, 253–260 (1999).

    Google Scholar 

  4. Osterman, F. A. Jr The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N. Engl. J. Med. 326, 414 (1992).

    Google Scholar 

  5. da Silva, A. F. et al. Audit Committee of the Vascular Surgical Society of Great Britain and Ireland The management and outcome of critical limb ischaemia in diabetic patients: results of a national survey. Diabet. Med. 13, 726–728 (1996).

    Google Scholar 

  6. Saluja, S. et al. Foot ulceration and its association with mortality in diabetes mellitus: a meta-analysis. Diabet. Med. 37, 211–218 (2020).

    Google Scholar 

  7. Monaghan, M. G., Borah, R., Thomsen, C. & Browne, S. Thou shall not heal: overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment. Adv. Drug Deliv. Rev. 203, 115120 (2023).

    Google Scholar 

  8. Li, M., Hou, Q., Zhong, L., Zhao, Y. & Fu, X. Macrophage related chronic inflammation in non-healing wounds. Front. Immunol. 12, 681710 (2021).

    Google Scholar 

  9. Vikram, A., Tripathi, D. N., Kumar, A. & Singh, S. Oxidative stress and inflammation in diabetic complications. Int. J. Endocrinol. 2014, 679754 (2014).

    Google Scholar 

  10. Bullon, P., Newman, H. N. & Battino, M. Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction?. Periodontology 2000 64, 139–153 (2014).

    Google Scholar 

  11. Puleston, D. J. et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab. 30, 352–363.e8 (2019).

    Google Scholar 

  12. Glorieux, C., Liu, S., Trachootham, D. & Huang, P. Targeting ROS in cancer: rationale and strategies. Nat. Rev. Drug Discov. 23, 583–606 (2024).

    Google Scholar 

  13. Formentini, L. et al. Mitochondrial ROS production protects the intestine from inflammation through functional M2 macrophage polarization. Cell Rep. 19, 1202–1213 (2017).

    Google Scholar 

  14. Fan, L. et al. Exosome-based mitochondrial delivery of circRNA mSCAR alleviates sepsis by orchestrating macrophage activation. Adv. Sci. 10, e2205692 (2023).

    Google Scholar 

  15. Wang, Y. A.-O. et al. Extracellular vesicles from 3D cultured dermal papilla cells improve wound healing via Krüppel-like factor 4/vascular endothelial growth factor A-driven angiogenesis. Burns Trauma 30, tkad034 (2023).

    Google Scholar 

  16. Wen, Y. et al. Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles. Extracell. Vesicle 1, 100004 (2022).

    Google Scholar 

  17. Jang, S. C. et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7, 7698–7710 (2013).

    Google Scholar 

  18. Lai, J., Huang, C., Guo, Y. & Rao, L. Engineered extracellular vesicles and their mimics in cardiovascular diseases. J. Control. Release 347, 27–43 (2022).

    Google Scholar 

  19. Gong, H. et al. Nanomaterial biointerfacing via mitochondrial membrane coating for targeted detoxification and molecular detection. Nano Lett. 21, 2603–2609 (2021).

    Google Scholar 

  20. Nakayama, T. Suppression of hydroperoxide-induced cytotoxicity by polyphenols. Cancer Res. 54, 1991s–1993s (1994).

    Google Scholar 

  21. Pavlíková, N. Caffeic acid and diseases—mechanisms of action. Int. J. Mol. Sci. 24, 588 (2022).

    Google Scholar 

  22. Chatterjee, S., Anslyn, E. V. & Bandyopadhyay, A. Boronic acid based dynamic click chemistry: recent advances and emergent applications. Chem. Sci. 12, 1585–1599 (2021).

    Google Scholar 

  23. Wang, P., Gong, Q., Hu, J., Li, X. & Zhang, X. Reactive oxygen species (ROS)-responsive prodrugs, probes, and theranostic prodrugs: applications in the ROS-related diseases. J. Med. Chem. 64, 298–325 (2020).

    Google Scholar 

  24. Larcher, A., Lebrun, A., Smietana, M. & Laurencin, D. A multinuclear NMR perspective on the complexation between bisboronic acids and bisbenzoxaboroles withcis-diols. New J. Chem. 42, 2815–2823 (2018).

    Google Scholar 

  25. Meadows, M. K., Roesner, E. K., Lynch, V. M., James, T. D. & Anslyn, E. V. Boronic acid mediated coupling of catechols and N-hydroxylamines: a bioorthogonal reaction to label peptides. Org. Lett. 19, 3179–3182 (2017).

    Google Scholar 

  26. Kolb, H. C., Finn, M. G. F., Sharpless, K. B. & Sharpless, K. B. Click Chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 40, 2004–2021 (2001).

    Google Scholar 

  27. Baker, P. J. et al. Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides. Infect. Immun. 62, 2257–2269 (1994).

    Google Scholar 

  28. Fahy, E. et al. A comprehensive classification system for lipids. J. Lipid Res. 46, 839–861 (2005).

    Google Scholar 

  29. Oprea, T. I. Property distribution of drug-related chemical databases. J. Comput Aided Mol. Des. 14, 251–264 (2000).

    Google Scholar 

  30. Dekant, W., Fujii, K., Shibata, E., Morita, O. & Shimotoyodome, A. Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements. Toxicol. Lett. 277, 104–108 (2017).

    Google Scholar 

  31. Magnani, C., Isaac, V. L. B., Correa, M. A. & Salgado, H. R. N. Caffeic acid: a review of its potential use in medications and cosmetics. Anal. Methods 6, 3203–3210 (2014).

    Google Scholar 

  32. Gandin, V., Khalkar, P., Braude, J. & Fernandes, A. P. Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment. Free Radic. Biol. Med. 127, 80–97 (2018).

    Google Scholar 

  33. Ghezzi, M. et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J. Control. Release 332, 312–336 (2021).

    Google Scholar 

  34. Wacławek, S. et al. Chemistry of persulfates in water and wastewater treatment: a review. Chem. Eng. J. 330, 44–62 (2017).

    Google Scholar 

  35. Wu, X. J. et al. A catalyst-free co-reaction system of long-lasting and intensive chemiluminescence applied to the detection of alkaline phosphatase. Mikrochim. Acta 189, 181 (2022).

    Google Scholar 

  36. Zielonka, J. et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem. Rev. 117, 10043–10120 (2017).

    Google Scholar 

  37. Bock, F. A.-O. & Tait, S. A.-O. X. Mitochondria as multifaceted regulators of cell death. Nat. Rev. Mol. Cell Biol. 21, 85–100 (2020).

    Google Scholar 

  38. Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res 107, 1058–1070 (2010).

    Google Scholar 

  39. Iversen, T.-G., Skotland, T. & Sandvig, K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 6, 176–185 (2011).

    Google Scholar 

  40. Leitinger, B. & Hogg, N. The involvement of lipid rafts in the regulation of integrin function. J. Cell Sci. 115, 963–972 (2002).

    Google Scholar 

  41. McMahon, H. T. & Boucrot, E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12, 517–533 (2011).

    Google Scholar 

  42. Bag, N., Yap, D. H. X. & Wohland, T. Temperature dependence of diffusion in model and live cell membranes characterized by imaging fluorescence correlation spectroscopy. Biochim. Biophysica Acta Biomembr. 1838, 802–813 (2014).

    Google Scholar 

  43. Gao, S. & Hu, J. Mitochondrial fusion: the machineries in and out. Trends Cell Biol. 31, 62–74 (2021).

    Google Scholar 

  44. Jiang, L. et al. Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery. Nat. Commun. 12, 2390 (2021).

    Google Scholar 

  45. Gao, C. et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 11, 2622 (2020).

    Google Scholar 

  46. Choi, D. et al. Quantitative proteomic analysis of trypsin-treated extracellular vesicles to identify the real-vesicular proteins. J. Extracell. Vesicles 9, 1757209 (2020).

    Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant No. 82402908 to L.F., Grant No. 82372523 to J.T.H., Grant No. 62475216 to B.P., Grant No. 82272261 to X.K.Y.), Key Research and Development Program of Shaanxi (Grant No. 2024SF-ZDCYL-04-10 to H.G., Grant No. 2024GH-ZDXM-37 to B.P., Grant No. 2022JC-58, 2024SF-ZDCYL-03-26 to X.K.Y.), Shaanxi Province Health Science Research and Innovation Capacity Enhancement Project (Grant No. 2025PT-03 to H.G.).

Author information

Author notes
  1. These authors contributed equally: Li Fan, Changhe Zhang.

Authors and Affiliations

  1. Department of Burns and Cutaneous Surgery, Xijing Hospital, The Fourth Military Medical University, Xi’an, China

    Li Fan, Zhigang Xu, Heng Li, Jingxiang Wang, Juntao Han, Hao Guan & Xuekang Yang

  2. Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia

    Changhe Zhang & Nicolas H. Voelcker

  3. Department of Ultrasound Diagnostics Tangdu Hospital, The Fourth Military Medical University, Xi’an, China

    Zhelong Li & Bin Zhang

  4. School of Pharmacy, The Fourth Military Medical University, Xi’an, China

    Zhao Wei

  5. State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Northwestern Polytechnical University, Xi’an, China

    Bo Peng

  6. Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, Clayton, VIC, Australia

    Nicolas H. Voelcker

  7. Materials Science and Engineering, Monash University, Clayton, VIC, Australia

    Nicolas H. Voelcker

Authors
  1. Li Fan
    View author publications

    Search author on:PubMed Google Scholar

  2. Changhe Zhang
    View author publications

    Search author on:PubMed Google Scholar

  3. Zhigang Xu
    View author publications

    Search author on:PubMed Google Scholar

  4. Zhelong Li
    View author publications

    Search author on:PubMed Google Scholar

  5. Bin Zhang
    View author publications

    Search author on:PubMed Google Scholar

  6. Heng Li
    View author publications

    Search author on:PubMed Google Scholar

  7. Jingxiang Wang
    View author publications

    Search author on:PubMed Google Scholar

  8. Zhao Wei
    View author publications

    Search author on:PubMed Google Scholar

  9. Juntao Han
    View author publications

    Search author on:PubMed Google Scholar

  10. Hao Guan
    View author publications

    Search author on:PubMed Google Scholar

  11. Bo Peng
    View author publications

    Search author on:PubMed Google Scholar

  12. Nicolas H. Voelcker
    View author publications

    Search author on:PubMed Google Scholar

  13. Xuekang Yang
    View author publications

    Search author on:PubMed Google Scholar

Contributions

L.F. and C.H.Z. collaborated to complete the study and drafted the manuscript. Z.G.X., Z.L.L., and B.Z. assisted with the preparation of nanovesicles. H.L. and J.X.W. assisted with animal experiments. Z.W., J.T.H., and H.G. provided technical help for this study. B.P., N.H.V., and X.K.Y. reviewed and edited the manuscript. All authors discussed the results and implications and commented on the paper.

Corresponding authors

Correspondence to Bo Peng, Nicolas H. Voelcker or Xuekang Yang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks Yun Liu and the other anonymous reviewers for their contribution to the peer review of this work. [A peer review file is available].

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Transparent Peer Review file (download PDF )

Source data

Source data (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, L., Zhang, C., Xu, Z. et al. Hybrid macrophage-mitochondria extracellular vesicles for mitochondrial ROS regulation in diabetic wounds. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69383-3

Download citation

  • Received: 21 July 2025

  • Accepted: 30 January 2026

  • Published: 28 February 2026

  • DOI: https://doi.org/10.1038/s41467-026-69383-3

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research